Header Logo

Connection

Charles Feldman to Streptolysins

Back to Details
This is a "connection" page, showing publications Charles Feldman has written about Streptolysins.
Charles Feldman
Connection Strength
4,879
Streptolysins
  1. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci. 2018 Apr 11; 19(4).
    View in: PubMed
    Score: 0,598
  2. Pneumolysin as a potential therapeutic target in severe pneumococcal disease. J Infect. 2017 06; 74(6):527-544.
    View in: PubMed
    Score: 0,555
  3. A pivotal role for pneumolysin in the immunopathogenesis, treatment and prevention of pneumococcal disease. S Afr Med J. 2007 Nov; 97(11 Pt 3):1141-5.
    View in: PubMed
    Score: 0,290
  4. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother. 2007 Nov; 60(5):1155-8.
    View in: PubMed
    Score: 0,287
  5. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother. 2007 Feb; 59(2):224-9.
    View in: PubMed
    Score: 0,274
  6. Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium. Int J Infect Dis. 2007 Jan; 11(1):11-5.
    View in: PubMed
    Score: 0,258
  7. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz). 2005 May-Jun; 53(3):189-98.
    View in: PubMed
    Score: 0,244
  8. Pro-inflammatory interactions of streptolysin O toxin with human neutrophils in vitro. J Immunotoxicol. 2024 Dec; 21(1):2345152.
    View in: PubMed
    Score: 0,227
  9. Pneumolysin in the immunopathogenesis and treatment of pneumococcal disease. Expert Rev Anti Infect Ther. 2003 Aug; 1(2):231-9.
    View in: PubMed
    Score: 0,216
  10. The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. Respir Med. 2002 Aug; 96(8):580-5.
    View in: PubMed
    Score: 0,202
  11. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis. 2002 Jun; 15(3):235-9.
    View in: PubMed
    Score: 0,199
  12. Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
    View in: PubMed
    Score: 0,172
  13. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017 12; 75(6):473-485.
    View in: PubMed
    Score: 0,144
  14. Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro. J Infect. 2017 06; 74(6):599-608.
    View in: PubMed
    Score: 0,139
  15. Pneumolysin Mediates Platelet Activation In Vitro. Lung. 2016 08; 194(4):589-93.
    View in: PubMed
    Score: 0,131
  16. Pneumolysin activates neutrophil extracellular trap formation. Clin Exp Immunol. 2016 06; 184(3):358-67.
    View in: PubMed
    Score: 0,129
  17. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J. 2013 Feb; 41(2):392-5.
    View in: PubMed
    Score: 0,100
  18. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol. 1991 Nov; 5(5):416-23.
    View in: PubMed
    Score: 0,096
  19. Characterization of the interactions of the pneumolysoid, ?6 PLY, with human neutrophils in vitro. Vaccine. 2011 Nov 08; 29(48):8780-2.
    View in: PubMed
    Score: 0,095
  20. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathog. 1990 Oct; 9(4):275-84.
    View in: PubMed
    Score: 0,089
  21. Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Eur Respir J. 2009 Nov; 34(5):1167-70.
    View in: PubMed
    Score: 0,083
  22. Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid. Clin Exp Immunol. 2005 May; 140(2):274-81.
    View in: PubMed
    Score: 0,061
  23. Pneumolysin potentiates oxidative inactivation of alpha-1-proteinase inhibitor by activated human neutrophils. Respir Med. 2004 Sep; 98(9):865-71.
    View in: PubMed
    Score: 0,058
  24. Docosahexaenoic acid and eicosapentaenoic acid antagonize the proinflammatory interactions of pneumolysin with human neutrophils. Infect Immun. 2004 Jul; 72(7):4327-9.
    View in: PubMed
    Score: 0,058
  25. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis. 2002 Aug 15; 186(4):562-5.
    View in: PubMed
    Score: 0,050
  26. Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun. 2001 May; 69(5):3494-6.
    View in: PubMed
    Score: 0,046
  27. Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis. 2001 Feb 15; 183(4):604-11.
    View in: PubMed
    Score: 0,045
  28. Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo. Infect Immun. 1992 Nov; 60(11):4969-72.
    View in: PubMed
    Score: 0,026
  29. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989 Jul; 57(7):2006-13.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.